396
Views
15
CrossRef citations to date
0
Altmetric
Article

Acute effects of multi-walled carbon nanotubes on primary bronchial epithelial cells from COPD patients

, ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 699-711 | Received 28 Aug 2017, Accepted 28 Apr 2018, Published online: 26 May 2018

References

  • Albini, A. 2015. “Environmental Impact of Multi-Wall Carbon Nanotubes in a Novel Model of Exposure: Systemic Distribution, Macrophage Accumulation, and Amyloid Deposition.” International Journal of Nanomedicine 10: 6133–6145.
  • Boyles, M. S. P., L. Young, D. M. Brown, L. MacCalman, H. Cowie, A. Moisala, F. Smail, et al. 2015. “Toxicology In Vitro Multi-Walled Carbon Nanotube Induced Frustrated Phagocytosis, Cytotoxicity and Pro-Inflammatory Conditions in Macrophages are Length Dependent and Greater Than That of Asbestos.” Toxicology In Vitro 29 (7): 1513–1528. Available at: http://dx.doi.org/10.1016/j.tiv.2015.06.012.
  • Chortarea, S., et al. 2017. “Human Asthmatic Bronchial Cells Are More Susceptible to Subchronic Repeated Exposures of Aerosolized Carbon Nanotubes At Occupationally Relevant Doses Than Healthy Cells.” ACS Nano 11: 7615–7625.
  • Chortarea, S., M. J. D. Clift, D. Vanhecke, C. Endes, P. Wick, A. Petri-Fink, B. Rothen-Rutishauser, et al. 2015. “Repeated Exposure to Carbon Nanotube-Based Aerosols Does Not Affect the Functional Properties of a 3D Human Epithelial Airway Model.” Nanotoxicology 9 (8): 983–911.
  • Clift, M. J. D., C. Endes, D. Vanhecke, P. Wick, P. Gehr, R. P. F. Schins, A. Petri-Fink, et al. 2014. “A Comparative Study of Different In Vitro Lung Cell Culture Systems to Assess the Most Beneficial Tool for Screening the Potential Adverse Effects of Carbon Nanotubes.” Toxicological Sciences 137 (1): 55–64.
  • Di Benedetto, G., C. J. Magnus, P. T. Gray, and A. Mehta. 1991. “Calcium Regulation of Ciliary Beat Frequency in Human Respiratory Epithelium In Vitro.” The Journal of Physiology 439 (1): 103–113.
  • Di Stefano, A., A. Capelli, and C. F. Donner. 2004. “Role of Interleukin-8 in the Pathogenesis and Treatment of COPD.” Chest Journal 126: 676–678.
  • Donaldson, K., et al. 2006. “Carbon Nanotubes: A Review of their Properties in Relation to Pulmonary Toxicology and Workplace Safety.” Toxicological Sciences: An Official Journal of the Society of Toxicology 92 (1): 5–22. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16484287.
  • Donaldson, K., F. A. Murphy, R. Duffin, C. A. Poland. 2010. “Asbestos, Carbon Nanotubes and the Pleural Mesothelium: A Review of the Hypothesis Regarding the Role of Long Fibre Retention in the Parietal Pleura, Inflammation and Mesothelioma.” Particle and Fibre Toxicology 7 (1):5.
  • Endes, C., et al. 2014. “An In Vitro Testing Strategy towards Mimicking the Inhalation of High Aspect Ratio Nanoparticles.” Particle and Fibre Toxicology, 11: 40. Available at: http://www.particleandfibretoxicology.com/content/11/1/40.
  • Erdely, A., et al. 2013. “Carbon Nanotube Dosimetry: From Workplace Exposure Assessment to Inhalation Toxicology.” Particle and Fibre Toxicology, 10: 53.
  • Fadeel, B., V. Kagan, H. Krug, A. Shvedova, M. Svartengren, L. Tran, L. Wiklund, et al. 2007. “There’s Plenty of Room at the Forum: Potential Risks and Safety Assessment of Engineered Nanomaterials.” Nanotoxicology 1 (2): 73–84.
  • Gangwal, S., J. S. Brown, A. Wang, K. A. Houck, D. J. Dix, R. J. Kavlock, E. A. C. Hubal, et al. 2011. “Informing Selection of Nanomaterial Concentrations for ToxCast In Vitro Testing Based on Occupational Exposure Potential.” Environmental Health Perspectives 119 (11): 1539–1546.
  • Gasser, M., P. Wick, M. J. D. Clift, F. Blank, L. Diener, B. Yan, P. Gehr, et al. 2012. “Pulmonary Surfactant Coating of Multi-Walled Carbon Nanotubes (MWCNTs) Influences their Oxidative and Pro-Inflammatory Potential In Vitro.” Particle and Fibre Toxicology 1 (9): 17. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3496593&tool=pmcentrez&rendertype=abstract.
  • Hussain, S., S. Sangtian, S. M. Anderson, R. J. Snyder, J. D. Marshburn, A. B. Rice, J. C. Bonner, et al. 2014. “Inflammasome Activation in Airway Epithelial Cells After Multi-walled Carbon Nanotube Exposure Mediates a Profibrotic Response in Lung Fibroblasts.” Particle and fibre toxicology, 11: 28.
  • Ji, J. et al. 2017. “Development of Combining of Human Bronchial Mucosa Models with Xpose ALI® for Exposure of Air Pollution Nanoparticles.” PLoS One 12: e0170428.
  • Johnston, H. J., G. R. Hutchison, F. M. Christensen, S. Peters, S. Hankin, K. Aschberger, V. Stone, et al. 2010. “A Critical Review of the Biological Mechanisms Underlying the In Vivo and In Vitro Toxicity of Carbon Nanotubes: The Contribution of Physico-Chemical Characteristics.” Nanotoxicology 4 (2): 207–246.
  • Königshoff, M., N. Kneidinger, O. Eickelberg. 2009. TGF-β Signalling in COPD: Deciphering Genetic and Cellular Susceptibilities for Future Therapeutic Regimens.” Swiss Medical Weekly 9: 554–563.
  • Lappalainen, U. et al. 2005. “Interleukin-1 Causes Pulmonary Inflammation, Emphysema, and Airway Remodeling in the Adult Murine Lung.” The American Journal of Respiratory Cell and Molecular Biology 32: 311–318.
  • Lenz, A., E. Karg, B. Lentner, V. Dittrich, C. Brandenberger, B. Rothen-Rutishauser, H. Schulz, et al. 2009. “A Dose-Controlled System for Air-Liquid Interface Cell Exposure and Application to Zinc Oxide Nanoparticles.” Particle and Fibre Toxicology 6 (1): 32. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid =2804607&tool=pmcentrez&rendertype=abstract. [Accessed December 23, 2013].
  • Luanpitpong, S., L. Wang, and Y. Rojanasakul. 2016. “The Effects of Carbon Nanotubes on Lung and Dermal Cellular Behaviors.” Nanomedicine (London) 16 (3): 338–348.
  • Ma-Hock, L., S. Treumann, V. Strauss, S. Brill, F. Luizi, M. Mertler, K. Wiench, et al. 2009. “Inhalation Toxicity of Multiwall Carbon Nanotubes in Rats Exposed for 3 Months.” Toxicological Sciences 112 (2): 468–481.
  • Mak, J. C.W., M. M. W. Chan-Yeung, S. P. Ho, K. S. Chan, K. Choo, K. S. Yee, C. H. Chau, et al. 2009. “Elevated Plasma TGF-b1 Levels in Patients with Chronic Obstructive Pulmonary Disease.” Respiratory Medicine 103 (7): 1083–1089. Available at: http://dx.doi.org/10.1016/j.rmed.2009.01.005.
  • Monteiller, C., L. Tran, W. MacNee, S. Faux, A. Jones, B. Miller, K. Donaldson, et al. 2007. “The Pro-Inflammatory Effects of Low-Toxicity Low-Solubility Particles, Nanoparticles and Fine Particles, on Epithelial Cells In Vitro: The Role of Surface Area.” Occupational and Environmental Medicine 64(9): 609–615.
  • Navarrette, C. R., J. H. Sisson, E. Nance, D. Allen-Gipson, J. Hanes, T. A. Wyatt. 2012. “Particulate Matter in Cigarette Smoke Increases Ciliary Axoneme Beating Through Mechanical Stimulation.” Journal of Aerosol Medicine and Pulmonary Drug Delivery 25 (3): 159–168.
  • NIOSH. 2013. NIOSH: Current Intelligence Bulletin 65: Occupational Exposure to Carbon Nanotubes and Nanofibers. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health, DHHS (NIOSH). p. 2013–145.
  • Oberdrster, G. 2001. “Pulmonary Effects of Inhaled Ultrafine Particles.” International Archives of Occupational and Environmental Health 74 (1): 1–8.
  • Oberdörster, G., V. Castranova, B. Asgharian, P. Sayre. 2015. “Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry.” Journal of Toxicology and Environmental Health 18 (3–4): 121–3054.
  • Oberdörster, G., E. Oberdörster, and J. Oberdörster. 2005. “Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles.” Environmental Health Perspectives 113 (7): 823–839.
  • Polk, W. W., M. Sharma, C. M. Sayes, J. A. Hotchkiss, A. J. Clippinger. 2016. “Aerosol Generation and Characterization of Multi-Walled Carbon Nanotubes Exposed to Cells Cultured at the Air-Liquid Interface.” Particle and Fibre Toxicology 13 (1): 1–12. Available at: http://dx.doi.org/10.1186/s12989-016-0131-y.
  • Quint, J. K., G. C. Donaldson, and J. J. P. Goldring. 2010. “Serum IP-10 as a Biomarker of Human Rhinovirus Infection at Exacerbation of COPD.” Chest 137: 812–822.
  • Schweiz, L. 2018. “COPD.” Available at: https://www.lungenliga.ch/de/krankheiten-ihre-folgen/copd.html.
  • Snyder, R. J., S. Hussain, C. J. Tucker, S. H. Randell, S. Garantziotis. 2017. “Impaired Ciliogenesis in Differentiating Human Bronchial Epithelia Exposed to Non-Cytotoxic Doses of Multi-Walled Carbon Nanotubes.” Particle and Fibre Toxicology 14 (1): 1–14.
  • Snyder-Talkington, B. N., M. Pacurari, C. Dong, S. S. Leonard, D. Schwegler-Berry, V. Castranova, Y. Qian, N. L. Guo. 2018. “Systematic Analysis of Multiwalled Carbon Nanotube-Induced Cellular Signaling and Gene Expression in Human Small Airway Epithelial Cells.” Toxicological Sciences 133 (1): 79–89.
  • Snyder-Talkington, B. N, D. Schwegler-Berry, V. Castranova, Y. Qian, N. L. Guo. 2013. “Multi-Walled Carbon Nanotubes Induce Human Microvascular Endothelial Cellular Effects in an Alveolar-Capillary Co-Culture with Small Airway Epithelial Cells.” Particle and Fibre Toxicology 10 (1): 35.
  • Steiropoulos, P. 2014. “New Developments in the Management of COPD: Clinical Utility of Indacaterol 75 μg.” International Journal of Chronic Obstructive Pulmonary Disease 9: 1–7. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3862584&tool=pmcentrez&rendertype=abstract.
  • Stueckle, T. A., D. C. Davidson, R. Derk, P. Wang, S. Friend, D. Schwegler-Berry, P. Zheng, et al. 2017. “Effect of Surface Functionalizations of Multi-walled Carbon Nanotubes on Neoplastic Transformation Potential in Primary Human Lung Epithelial Cells.” Nanotoxicology, 11, 613–624.
  • Thurnherr, T. C. Brandenberger, K. Fischer, L. Diener, P. Manser, X. Maeder-Althaus, J.-P. Kaiser, et al. 2011. “A Comparison of Acute and Long-Term Effects of Industrial Multiwalled Carbon Nanotubes on Human Lung and Immune Cells In Vitro.” Toxicology Letters 200 (3): 176–186.
  • Thurnherr, T., D. S. Su, L. Diener, G. Weinberg, P. Manser, N. Pfänder, R. Arrigo, et al. 2009. “Comprehensive Evaluation of In Vitro Toxicity of Three Large-Scale Produced Carbon Nanotubes on Human Jurkat T Cells and a Comparison to Crocidolite Asbestos.” Nanotoxicology 3 (4): 319–338.
  • Vietti, G., et al. 2013. “Towards Predicting the Lung Fibrogenic Activity of Nanomaterials: Experimental Validation of an In Vitro Fibroblast Proliferation Assay.” Particle and Fibre Toxicology 10: 52.
  • van Berlo, D., V. Wilhelmi, A. W. Boots, M. Hullmann, T. A. J. Kuhlbusch, A. Bast, R. P. F. Schins, et al. 2014. “Apoptotic, Inflammatory, and Fibrogenic Effects of Two Different Types of Multi-Walled Carbon Nanotubes in Mouse Lung.” Archives in Toxicology 88 (9): 1725–1737.
  • Wei, J., et al. 2015. “Association Between Serum Interleukin-6 Concentrations and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.” Peer Journal 3: e1199.
  • World Health Organization (WHO). 2017. “Chronic obstructive pulmonary disease (COPD).” World Health Organization. http://www.who.int/respiratory/copd/en/.
  • Zavala, J., B. O’Brien, K. Lichtveld, K. G. Sexton, I. Rusyn, I. Jaspers, W. Vizuete, et al. 2016. “Assessment of Biological Responses of EpiAirwayTM 3-D Cell Constructs vs. A549 Cells for Determining Toxicity of Ambient Air Pollution.” Inhalation Toxicology 28 (6): 251–259.
  • Zhang, X., H. Zheng, H. Zhang, W. Ma, F. Wang, C. Liu, S. He, et al. 2011. “Cytokine Increased Interleukin (IL)-8 and Decreased IL-17 Production in Chronic Obstructive Pulmonary Disease (COPD) Provoked by Cigarette Smoke.” Cytokine 56 (3): 717–725.
  • Zhou, H., X. Ying, Y. Liu, S. Ye, J. Yan, Y. Li. 2017. “Genetic Polymorphism of Heme Oxygenase 1 Promoter in the Occurrence and Severity of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.” Journal of Cellular and Molecular Medicine 21 (5): 894–903.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.